Given the pivotal role of the TGF-β/Smad pathway in liver fibrosis induced by LBP, this study investigated whether targeting LBP or the TGF-β/Smad pathway could effectively prevent and treat GC-LM. This evidence concerns the gene LBP and lymphangioma.